Market cap: $1,541,976,148
Exchange: NYS
Sector: Health Technology
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Company Name
Arcus Biosciences Inc
Average Volume (10 days)
555,649
Average Volume (30 days)
764,026
Moving Average (50 days)
$18.22
Moving Average (200 days)
$16.74
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
-5.0227
Market Cap
1,541,976,148
Shares Outstanding
90,864,829
52-Week High Split Adjust Only
25.47
52-Week Low Split Adjust Only
12.95
Employee Count
511
Beta
1.4066
Next Earnings Date
2024-05-09
TTM Dividend Rate Per Share
0
Past 5 days
-0.08%
Past 30 days
-0.06%
Past 3 months
-0.1%
Past 6 months
0.02%
Past year
-0.03%
Past 2 years
-0.5%
Past 5 years
0.32%
Max % Change
0%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Arcus Biosciences Inc | RCUS | n/a | n/a | n/a | n/a | n/a |
| Peer Avg | N/A | 3.32 | -1.07 | -7.2 | 3.32 | 4.06 |
| Olema Pharmaceuticals Inc | OLMA | n/a | n/a | -21.2 | n/a | n/a |
| Omeros Corporation | OMER | 13.27 | -4.27 | -7.7 | 13.27 | 16.24 |
| Omega Therapeutics Inc | OMGA | n/a | n/a | n/a | n/a | n/a |